menu search

Here's the playbook mantle ridge may use to boost profitability at dollar tree

mantle Ridge's Paul Hilal has a track record of creating value by bringing on rock-star CEOs. Here's ho...

November 20, 2021, 8:12 am

Here's the playbook mantle ridge may use to boost profitability at dollar tree

mantle Ridge's Paul Hilal has a track record of creating value by bringing on rock-star CEOs. Here's ho...

November 20, 2021, 8:12 am

Here's the playbook mantle ridge may use to boost profitability at dollar tree

mantle Ridge's Paul Hilal has a track record of creating value by bringing on rock-star CEOs. Here's ho...

November 20, 2021, 8:12 am

10 things to know about the activist investor lifting dollar tree stock today

Dollar Tree stock is trading 14% higher today on news that mantle Ridge is taking a $1.8 billion stake ...

November 15, 2021, 1:51 pm

10 things to know about the activist investor lifting dollar tree stock today

Dollar Tree stock is trading 14% higher today on news that mantle Ridge is taking a $1.8 billion stake ...

November 15, 2021, 1:51 pm

10 things to know about the activist investor lifting dollar tree stock today

Dollar Tree stock is trading 14% higher today on news that mantle Ridge is taking a $1.8 billion stake ...

November 15, 2021, 1:51 pm

Beigene announces brukinsa® (zanubrutinib) approved for treatment of patients with mantle cell lymphoma in australia

CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)---- $BGNE #BTKi--BeiGene Announces BRUKINSA® (Zanubrutinib) Approved for Treatment of Patients with ...

October 10, 2021, 5:00 pm

Beigene announces brukinsa® (zanubrutinib) approved for treatment of patients with mantle cell lymphoma

SYDNEY & CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)---- $BGNE #BTKi--BeiGene Announces BRUKINSA® (Zanubrutinib) Approved for Treatment of Patients w...

October 10, 2021, 5:00 pm

Beigene announces brukinsa® (zanubrutinib) approved for treatment of patients with mantle cell lymphoma in australia

CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)---- $BGNE #BTKi--BeiGene Announces BRUKINSA® (Zanubrutinib) Approved for Treatment of Patients with ...

October 10, 2021, 5:00 pm

Beigene announces brukinsa® (zanubrutinib) approved for treatment of patients with mantle cell lymphoma

SYDNEY & CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)---- $BGNE #BTKi--BeiGene Announces BRUKINSA® (Zanubrutinib) Approved for Treatment of Patients w...

October 10, 2021, 5:00 pm

Beigene announces brukinsa® (zanubrutinib) approved for treatment of patients with mantle cell lymphoma in australia

CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)---- $BGNE #BTKi--BeiGene Announces BRUKINSA® (Zanubrutinib) Approved for Treatment of Patients with ...

October 10, 2021, 5:00 pm

Beigene announces brukinsa® (zanubrutinib) approved for treatment of patients with mantle cell lymphoma

SYDNEY & CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)---- $BGNE #BTKi--BeiGene Announces BRUKINSA® (Zanubrutinib) Approved for Treatment of Patients w...

October 10, 2021, 5:00 pm


Search within

Pages Search Results: